Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Migoprotafib by F. Hoffmann-La Roche for Metastatic Colorectal Cancer: Likelihood of Approval
Migoprotafib is under clinical development by F. Hoffmann-La Roche and currently in Phase I for Metastatic Colorectal Cancer. According to...
Data Insights
Migoprotafib by F. Hoffmann-La Roche for Solid Tumor: Likelihood of Approval
Migoprotafib is under clinical development by F. Hoffmann-La Roche and currently in Phase I for Solid Tumor. According to GlobalData,...